The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure model

Epilepsy Research

Volumn 67, Issue 1-2, 2005, Pages 81-87

  Duncan, Gary E ^a   Kohn, Harold ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

2 Deoxyglucose; 6 Hz; Antiepileptic drug; Brain metabolism; Cerebral cortex; Hippocampus; Lacosamide; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; DEOXYGLUCOSE; HARKOSERIDE; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR; BRAIN CORTEX; BRAIN DEPTH STIMULATION; BRAIN METABOLISM; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; CORNEA; DRUG EFFECT; ELECTRODE; ELECTROSTIMULATION; EXPERIMENTAL MODEL; GLUCOSE METABOLISM; HEXOSE TRANSPORT; HIPPOCAMPUS; HYPOTHALAMUS; METABOLIC ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; TEMPORAL LOBE EPILEPSY; THALAMUS;

ACETAMIDES; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; CARBON RADIOISOTOPES; CEREBRAL CORTEX; DEOXYGLUCOSE; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; EPILEPSY, COMPLEX PARTIAL; GLUCOSE; HIPPOCAMPUS; MICE;

EID: 27644510366     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2005.08.009     Document Type: Article

References (32)

1. S.P. Aiken, and W.M. Brown Treatment of epilepsy: existing therapies and future developments Front. Biosci. 5 2000 124 152
2. M.E. Barton, B.D. Klein, H.H. Wolf, and H.S. White Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy Epilepsy Res. 47 2001 217 227
3. M.E. Barton, S.C. Peters, and H.E. Shannon Comparison of the effect of glutamate receptor modulators in the 6 Hz and maximal electroshock seizure models Epilepsy Res. 56 2003 17 26
4. J. Bauer, and M. Reuber Medical treatment of epilepsy Expert Opin. Emerg. Drugs 8 2003 457 467
5. E. Ben-Menachem, V. Biton, and D. Jatuzis Efficacy and safety of adjunctive oral lacosamide for the treatment of partial onset seizures in patients with epilepsy Neurology 64 2005 A187
6. M. Bialer, S.I. Johannessen, H.J. Kupferberg, R.H. Levy, P. Loiseau, and E. Perucca Progress report on new antiepileptic drugs: a summary of the fifth Eilat conference Epilepsy Res. 43 2001 11 58
7. M.J. Brodie, and M.A. Dichter Antiepileptic drugs New Engl. J. Med. 334 1996 168 175
8. W.C. Brown, D.O. Schiffman, E.A. Swinyard, and L.S. Goodman Comparative assay of antiepileptic drugs by "psychomotor" seizure test and minimal electroshock threshold test J. Pharmacol. Exp. Ther. 107 1953 273 283
9. D. Choi, J.P. Stables, and H. Kohn Synthesis and anticonvulsant activities of N-benzyl-2-acetamidopropionamide derivatives J. Med. Chem. 39 1996 1907 1916
10. S. Cortes, Z.-K. Liao, D. Watson, and H. Kohn Effect of structural modification of the hydantoin ring on anticonvulsant activity J. Med. Chem. 28 1985 601 606
11. G.E. Duncan, K.B. Johnson, and G.R.T. Breese Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity J. Neurosci. 13 1993 3932 3943
12. G.E. Duncan, W.E. Stumpf, and C. Pilgrim Cerebral metabolic mapping at the cellular level with dry-mount autoradiography of H-3 2-deoxyglucose Brain Res. 401 1987 43 49
13. J.S. Duncan The promise of new antiepileptic drugs Br. J. Clin. Pharmacol. 53 2002 123 131
14. G.E. Duncan, S. Miyamoto, H.B. Gu, J.A. Lieberman, B.H. Koller, and J.N. Snouwaert Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function Brain Res. 951 2002 166 176
15. M. Erecinska, and I.A. Silver Ions and energy in mammalian brain Prog. Neurobiol. 43 1994 37 71
16. C.A. Hovinga Novel anticonvulsant medications in development Expert Opin. Investig. Drugs 11 2002 1387 1406
17. C.A. Hovinga SPM-927 Schwarz Pharma IDrugs 6 2003 479 485
18. R.M. Kaminski, M.R. Livingood, and M.A. Rogawski Allopregnanolone analogs that positively modulate GABA(A) receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice Epilepsia 45 2004 864 867
19. H. Kohn, and J.D. Conley New antiepileptic agents Chem. Br. 24 1988 231 234
20. T.G. Kokate, B.E. Svensson, and M.A. Rogawski Anticonvulsant activity of neurosteroids - correlation with gamma-aminobutyric acid-evoked chloride current potentiation J. Pharmacol. Exp. Ther. 270 1994 1223 1229
21. P.A. Lehmann Quantifying stereoselectivity or how to choose a pair of shoes when you have two left feet Trends Pharmacol. Sci. 3 1982 103 106
22. R.H. Levy, R. Mattson, and B. Meldrum Antiepileptic Drugs fourth ed. 1995 Raven Press New York
23. W. Loscher, and D. Honack Profile of Ucb-L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats Eur. J. Pharmacol. 232 1993 147 158
24. R.H. Mattson, J.A. Cramer, J.F. Collins, and D.B. Smith Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures New Engl. J. Med. 313 1985 145 151
25. G. McCleane, B. Koch, and C. Rauschkolb Does SPM 927 have an analgesic effect in human neuropathic pain? An open label study Neurosci. Lett. 352 2003 117 120
26. D. McCorry, D. Chadwick, and A. Marson Current drug treatment of epilepsy in adults Lancet Neurol. 3 2004 729 735
27. J.O. McNamara J.G. Hardman L.E. Limbird Goodman & Gilman's The Pharmacological Basis of Therapeutics 10th ed. 2001 McGraw-Hill New York 521 547 (Chapter 21)
28. A.B. Patel, T.A. de Graaf, T.F. Mason, T. Kanamatsu, T.L. Rothman, R.G. Shulman, and K.L. Behar Glutamatergic neurotransmission and neuronal glucose oxidation are coupled during intense neuronal activation J. Cereb. Blood Flow Metabol. 24 2004 972 985
29. J.M. Pellock, and L.J. Willmore A rational guide to monitoring in patients receiving anticonvulsants Neurology 41 1991 961 964
30. M.A. Rogawski, and R.J. Porter Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising development stage compounds Pharmacol. Rev. 42 1997 223 286
31. R.C. Sachdeo, G.D. Montouris, and R.P. Hull An open-label, dose titration trial to evaluate tolerability and efficacy of oral SPM927 as adjunctive therapy in patients with partial seizures Neurology 60 2003 A433
32. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat J. Neurochem. 28 1977 897 916